Diabetes and vision care study in Bangladesh
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study tests a program that combines diabetes care with eye exams for people in Bangladesh who were recently diagnosed with diabetes. The goal is to see if this approach helps you better manage your health and prevent vision problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with diabetes in the last 6 months
- Age 30 or older
- Getting treatment at the Dinajpur Diabetes Hospital
- Have a mobile phone that can receive voice messages
- Willing to join the study and give your consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to combine diabetes care with eye care for people with diabetes in Bangladesh. If you have diabetes and a diabetes-related eye condition, this might help improve your care.
This study tests a new camera software to help general practitioners check for diabetic retinopathy, an eye problem caused by diabetes. It is for people with type 1 or 2 diabetes who are 40 or older.
This study looks at how common diabetic retinopathy is and what factors increase the risk. It may help find better ways to prevent vision loss in people with diabetes.
This trial is studying people living in Char Fasson, Bangladesh, to see who might have undiagnosed eye problems. It's a local screening program to catch eye issues early.
This study looks at how fat and sugar levels in the blood relate to different stages of eye damage in people with type 2 diabetes. It may help find new ways to treat or prevent vision loss.
This trial is looking at whether newer diabetes drugs (like SGLT2 inhibitors and DPP-4 inhibitors) can help protect the eyes of people with long-standing type 2 diabetes. The study focuses on preventing or slowing diabetic retinopathy, a common eye complication.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.